Interstitial lung disease (ILD) is an umbrella term covering over 100 distinct conditions, and is often used interchangeably with the term pulmonary fibrosis. Dr. Lee covers the main types, causes and risk factors.

Learn more about Dr. Lee here: https://www.uchealth.org/provider/joyce-lee—pulmonary-disease/
Learn more about UCHealth Lung and respiratory care services here: https://www.uchealth.org/services/respiratory-lung-care/

UCHEALTH ACROSS THE WEB:
UCHealth.org: https://bit.ly/UCHealthWeb
Facebook: https://bit.ly/UCHealthFB
Twitter: https://bit.ly/UCHealthTwitter
Pinterest: https://bit.ly/UCHealthPin
Instagram: https://bit.ly/UCHealthIG
Video Rating: / 5

Premium Member Resources: https://www.ninjanerd.org/lecture/restrictive-lung-disease

Ninja Nerds!
Professor Zach Murphy will be presenting on Restrictive Lung Disease. We will be going into detail on the following main objectives:

1. Definition and Classification of Restrictive Lung Disease
– Gain insights into what constitutes restrictive lung disease and how it varies from obstructive lung conditions.
– Acquaint yourself with the classifications based on etiology, such as intrinsic lung diseases (interstitial lung disease, fibrosis) and extrinsic factors (pleural diseases, neuromuscular disorders).

2. Pathophysiology and Etiologies
– Explore the underlying mechanisms contributing to restrictive lung disease, ranging from inflammation and fibrosis to pleural effusions and chest wall deformities.
– Understand the altered lung mechanics and its relationship to the various causative factors.

3. Clinical Manifestations and Presentation
– Learn to recognize the signs and symptoms commonly associated with restrictive lung disease, such as dyspnea, reduced exercise tolerance, and dry cough.
– Identify potential indicators of severity, such as hypoxia, tachypnea, and the use of accessory respiratory muscles.

4. Diagnostic Criteria and Tools
– Understand the roles and interpretations of various diagnostic tests, including pulmonary function tests (PFTs), high-resolution computed tomography (HRCT), and lung biopsy.
– Familiarize yourself with the latest guidelines for diagnosing restrictive lung disease as outlined by professional bodies like the American Thoracic Society.

5. Initial Management Strategies
– Discuss evidence-based approaches for initial symptom management, such as oxygen supplementation and corticosteroids.
– Learn about the importance of supportive therapies, including physiotherapy and pulmonary rehabilitation, in enhancing quality of life.

6. Definitive Management Approaches
– Examine the various treatment options available, ranging from pharmacological interventions like antifibrotic agents to surgical procedures like lung transplantation.
– Evaluate the risks and benefits of each approach, grounded in the latest research and guidelines.

7. Complications and Prognosis
– Gain an understanding of the potential complications arising from untreated or improperly managed restrictive lung disease, such as respiratory failure and pulmonary hypertension.
– Discuss the prognostic indicators and how variables like age, lung function, and comorbidities may influence outcomes.

Table of Contents:
0:00 Lab
0:07 Restrictive Lung Disease Introduction
0:37 Pathophysiology | Intrinsic Lung Diseases
8:07 Pathophysiology | Extrinsic Lung Diseases
11:45 Complications | Respiratory Failure
15:52 Complications | Cor Pulmonale
19:42 Complications | Lung Cancer
21:55 Diagnostic Approach
27:11 Treatment
29:29 Comment, Like, SUBSCRIBE!

Retired Ninja Nerd Lectures:

Ninja Nerd Website | https://ninjanerd.org

Ninja Nerd Podcast | https://podcast.ninjanerd.org

Ninja Nerd Store | https://merch.ninjanerd.org

https://www.instagram.com/ninjanerdlectures/
https://www.tiktok.com/@ninjanerdlectures
https://www.facebook.com/NinjaNerdLectures/
https://twitter.com/@NinjaNerdSci
https://discord.gg/@TAsV8BGd

#ninjanerd #respiratory #restrictivelungdiseases

Share this page:

What is restrictive lung disease? It occur when lung tissue becomes fibrotic and firm which reduces the total lung capacity.

Find more videos at http://osms.it/more.

Join over 3 million current & future clinicians who learn by Osmosis, and over 130 universities around the world who partner with us to make medical and health education more engaging and efficient. We have unparalleled tools and materials to prepare you to succeed in school, on board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. If you’re interested in exploring an institutional partnership, visit osmosis.org/educators to request a personalized demo.

Follow us on social:
Facebook: http://osms.it/facebook
Twitter: http://osms.it/twitter
Instagram for med: http://osms.it/instagram
Instagram for nursing: https://osms.it/ignursing
Linkedin: https://osms.it/linkedin

Our Vision: Everyone who cares for someone will learn by Osmosis.
Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: http://osms.it/mission

Medical disclaimer: Knowledge Diffusion Inc (DBA Osmosis) does not provide medical advice. Osmosis and the content available on Osmosis’s properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed health care provider. Always seek the advice of a physician or other qualified healthcare provider with any questions you have regarding a medical condition. © 2023 Elsevier. All rights reserved.
Video Rating: / 5

Share this page:

Where do I get my information from: http://armandoh.org/resource

“Interstitial lung disease also known as diffuse parenchymal lung diseases (DPLDs) are a group of disorders based on similar clinical, radiographic, physiologic, and pathologic changes.

Present primarily with shortness of breath and a non productive cough usually chronic over weeks to months without response to initial treatment of puffers. If there is clinical suspicion of ILD a full pulmonary function test should be done. Characteristic changes of ILD include: reduced total lung capacity (TLC) and DLCO.

The diffuse parenchymal lung diseases are divided into those that are associated with known causes or unknown causes and other weird and wonderful rare causes.”

Support me:
🖼️ Buy PDFs: http://armandoh.org/shop
💵 Patreon: http://www.patreon.com/armando
👕 Buy shirts: https://teespring.com/stores/ah-7

Social media:
📷 Instagram: http://instagram.com/armandohasudungan
🐦 Twitter: https://twitter.com/armandohasudung
📔 Facebook: https://www.facebook.com/ArmandoHasudungan

Resources:
📕 Books: http://armandoh.org/resource
🎞️ Equipment: armandoh.org/armando-faigl

You can send me mail:
📫 PO BOX 166, Randwick NSW 2031, Australia

Share this page:

An overview of ILD (also known as diffuse parenchymal lung diseases), including definition, classification, etiologies, and diagnostic evaluation (e.g. CT and PFT findings).
Video Rating: / 5

Share this page: